| Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. | |
| | |
MedLine Citation:
|
PMID: 23036075 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Inflammatory bowel disease (IBD) is a chronic relapsing idiopathic disease. In clinical terms, most patients require lifelong medication associated with possible unpleasant adverse effects. Oral colon-specific drug delivery systems are designed to deliver therapeutic drugs to the inflamed colon to target pathophysiological manifestations of IBD. The aim is to maintain the drug with proper concentration in the inflamed colon, to enhance drug residence time and to minimize drug absorption by healthy tissues. AREAS COVERED: This review addresses the main barriers for colon-specific drug delivery from organism, tissue and cell levels, respectively. It also summarizes novel colon-specific therapeutic strategies using microparticles and nanoparticles. EXPERT OPINION: Oral colon-specific drug delivery represents a possible approach toward efficient treatment of IBD. As the environment of the gastrointestinal tract is harsh and intricate, this approach requires that drug carriers can respond to specific environmental factors of the inflamed colon, permitting stimulus-responsive release of loaded drugs to specific cells or even into specific organelles within cells. |
| | |
Authors:
|
Bo Xiao; Didier Merlin |
Related Documents
:
|
7957505 - H2-receptor antagonists are scavengers of oxygen radicals. 2517505 - Effects of sodium valproate and oxygen on the craniofacial skeletal pattern in the cd-1... 16638925 - Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-se... 17504005 - Evaluation of ecg time intervals in a rabbit model of anthracycline-induced cardiomyopa... 6119725 - Enhancement of the avoidance-suppressing effects of neuroleptic agents after repeated a... 4005115 - Oxprenolol absorption in man after single bolus dosing into two segments of the colon c... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review Date: 2012-10-05 |
Journal Detail:
|
Title: Expert opinion on drug delivery Volume: 9 ISSN: 1744-7593 ISO Abbreviation: Expert Opin Drug Deliv Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-10-22 Completed Date: 2013-04-26 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 101228421 Medline TA: Expert Opin Drug Deliv Country: England |
Other Details:
|
Languages: eng Pagination: 1393-407 Citation Subset: IM |
Affiliation:
|
Center for Diagnostics and Therapeutics, Department of Biology, Georgia State University, Atlanta, 30302, USA. bxiao@gsu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Animals Colon / drug effects* Drug Carriers Drug Delivery Systems* Humans Inflammatory Bowel Diseases / drug therapy* Nanoparticles / administration & dosage Pharmaceutical Preparations / administration & dosage |
| Grant Support | |
ID/Acronym/Agency:
|
R01-DK-071594/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Drug Carriers; 0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The feasibility of rapid baseline objective physical activity measurement in a natural experimental ...
Next Document: Cross-Cultural Adaptation and Validation of the Brazilian Portuguese Version of the Pain Catastrophi...